|
MAP3K3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.352600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.433200E-04 |
| Normal-vs-Stage2 |
1.019240E-01 |
| Normal-vs-Stage3 |
1.761620E-02 |
| Normal-vs-Stage4 |
1.370990E-01 |
| Stage1-vs-Stage2 |
5.457600E-01 |
| Stage1-vs-Stage3 |
8.931400E-01 |
| Stage1-vs-Stage4 |
6.818800E-01 |
| Stage2-vs-Stage3 |
6.287000E-01 |
| Stage2-vs-Stage4 |
4.428000E-01 |
| Stage3-vs-Stage4 |
6.351400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.225600E-04 |
| Normal-vs-AfricanAmerican |
8.939800E-03 |
| Normal-vs-Asian |
1.827370E-01 |
| Caucasian-vs-AfricanAmerican |
7.840400E-01 |
| Caucasian-vs-Asian |
7.383800E-01 |
| AfricanAmerican-vs-Asian |
6.356400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.178120E-04 |
| Normal-vs-Female |
1.220010E-01 |
| Male-vs-Female |
1.058800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.916300E-03 |
| Normal-vs-Extreme_Weight |
3.205000E-03 |
| Normal-vs-Obese |
5.483800E-03 |
| Normal-vs-Extreme_Obese |
2.822200E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.379400E-01 |
| Normal_Weight-vs-Obese |
5.838400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.024400E-01 |
| Extreme_Weight-vs-Obese |
8.386400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.486400E-01 |
| Obese-vs-Extreme_Obese |
2.271000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.753000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.098000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.89939999999389E-05 |
| Normal-vs-Age(81-100Yrs) |
4.515800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.657800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.879700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.398100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.765590E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.572820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.894100E-02 |
| Normal-VS-Type2 PRCC |
1.06280000022885E-07 |
| Normal-VS-KIRP CIMP |
9.391400E-01 |
| Normal-VS-Unclassified PRCC |
4.011600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.819400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.755000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.779600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.190160E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.899800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.923600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78560000000583E-05 |
| Normal-vs-N1 |
4.939700E-02 |
| Normal-vs-N2 |
9.552200E-01 |
| N0-vs-N1 |
3.392600E-01 |
| N0-vs-N2 |
1.332190E-01 |
| N1-vs-N2 |
3.910600E-01 |
|
|
